Objectives:

1. Illustrate the genetic variability of common neuromuscular phenotypes;

2. Delineate optimal, cost effective strategies for diagnosis of genetic muscle diseases;
3. Develop an understanding of genetic therapies for genetic muscle diseases, and understand the translatability of these techniques across the spectrum of disease; and
4. Introduce future paradigms related to management of genetic disorders.